By identifying promising discoveries and advancing their translation, CCRM has enabled and supported new companies. As of October 2023, we have co-founded one company, incubated a second, and supported the launch of 15 more (17 total) that together have raised more than CAN$1 million.

Portfolio Companies

Endogena Therapeutics
External link to ExCellThera
Feldan Therapeutics
Intelligent Vector Solutions - iVexSol logo
Kisoji Biotechnology
LineaBio logo
Morophocell Technologies
Notch Therapeutics

Past Exits

Learn more on our Investing Strategy and Funding and Strategic Support pages.